Congenital cataract does not greatly affect quality of life in young adults

Article

History of congenital cataract does not affect quality of life or educational achievements in adolescents and young adults.

History of congenital cataract does not affect quality of life or educational achievements in adolescents and young adults, claims a study in the Journal of Paediatric Ophthalmology and Strabismus.

Dr Caitriona Kirwan et al., Mater Private Hospital, Dublin, Ireland, performed a retrospective chart review on patients who underwent cataract surgery below the age of 24 months. The National Eye Institute 25-item Visual Function Questionnaire (NEI-VFQ-25) was used to assess vision-specific health-related quality of life in adolescents and young adults. A control group of healthy volunteers with no visual complaints was also included in the study.

Unilateral cataract was recorded in 16 patients, bilateral cataract in 22 patients and 15 people were in the control group. The bilateral participants experienced greater difficulty with regards to near and distance activities, compared to the unilateral group.

Between the unilateral and control group there were no significant differences in ocular pain, vision-specific social functioning, role difficulties and dependency scores. All patients attended main-stream school and the majority had attended university, meaning educational achievements were high in both cataract groups.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.